1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MAP3K
  4. MAP3K Inhibitors

MAP3K Inhibitors

MAP3K7/TAK1

MAP3K8/COT/Tpl2

MAP3K6/ASK2

MAP3K5/ASK1

MAP3K12/DLK/Pref-1

NIK/MAP3K14

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

MAP3K Inhibitors
Product Name MAP3K7/TAK1 MAP3K8/COT/Tpl2 MAP3K6/ASK2 MAP3K5/ASK1 MAP3K12/DLK/Pref-1 NIK/MAP3K14 Purity
Oleanolic acid      
ASK1
    98.0%
Takinib
TAK1, IC50: 9.5 nM
          99.48%
5Z-7-Oxozeaenol
TAK1, IC50: 8.1 nM
          99.60%
Selonsertib      
ASK1, pIC50: 8.3
    99.05%
CEP-14513        
MAP3K12/DLK
 
MAP3K14-IN-1          
NIK/MAP3K14, IC50: 1.8 nM
NG25
TAK1, IC50: 149 nM
          98.68%
Higenamine hydrochloride      
ASK1
    99.34%
Tpl2 Kinase Inhibitor 1  
MAP3K8/COT/Tpl2
        99.42%
NQDI-1      
ASK1, Ki: 500 nM
ASK1, IC50: 3 μM
    98.11%
TAK1-IN-2
TAK1, IC50: 2 nM
          98.75%
TAK1/MAP4K2 inhibitor 1
TAK1, IC50: 41.1 nM
          99.91%
ASK1-IN-2      
ASK1, IC50: 32.8 nM
    99.37%
TAK1-IN-3
TAK1
          99.83%
Pelubiprofen
TAK1
          98.46%
ASK1-IN-1      
ASK1
    98.74%
TAK1-IN-4
TAK1
          99.30%
TC ASK 10      
ASK1, IC50: 14 nM
    99.84%
TAK-756
TAK1, pIC50: 8.6
         
CBP-501
C-Tak1, IC50: 1.4 μM
          99.75%
ASK1-IN-4      
ASK1, IC50: .2 μM
   
CS17919      
ASK1, IC50: 22.52 nM
   
Cot-IN-4  
MAP3K8/COT/Tpl2
       
CBP-501 acetate
C-Tak1, IC50: 1.4 μM
          99.75%
DDO3711    
MAP3K6/ASK2, IC50: >20 μM
     
DLK-IN-2        
MAP3K12/DLK
 
N-Acetylgalactosaminyltransferase 4      
ASK1
   
Cot-IN-5  
MAP3K8/COT/Tpl2
       
Tpl2 Kinase Inhibitor 1 hydrochloride  
MAP3K8/COT/Tpl2
       
ASK1-IN-3      
ASK1, IC50: 33.8 nM
   
MSC 2032964A      
ASK1, IC50: 96 nM
   
ASK1-IN-5      
ASK1
   
JT21-25      
ASK1, IC50: 5.1 nM